Magnetic brain stimulation with memory training for older adults with mild memory problems
Tests deep magnetic brain stimulation plus cognitive training in older adults with memory complaints.
Key facts
- Who runs it
- Rotman Research Institute at Baycrest
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 15 Nov 2025
- Expected to end
- 15 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active Brainsway H7-Coil Deep TMS System
- Sham Brainsway H1-Coil Deep TMS System
- Record updated
- 28 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for older adults with mild memory problems (mild cognitive impairment or subjective memory concerns). It tests deep brain magnetic stimulation (dTMS) together with cognitive training.
- Age
- 55 to 85 years (on the day of randomization)
- Sex
- Men, and women after menopause
- Disease stage
- Mild cognitive impairment (Montreal Cognitive Assessment score < 26 or a neuropsychological assessment), OR your own memory concerns plus a first degree relative, living or deceased, with probable or confirmed Alzheimer's disease (AD). Mini Mental State Examination (MMSE) score of 24 or higher.
- Earlier treatment
- Any medicines must have been stable for 2 months, with no change expected during the study. Cannot join if you regularly used benzodiazepines or other sleep medicines within 2 weeks of randomization.
Main reasons for not taking part
- Metal in the head, a cardiac pacemaker, an implanted medication pump or a central venous line
- Personal or family history of epilepsy, stroke, brain lesions, abnormal brain MRI or raised pressure in the brain
- History of psychotic disorder, bipolar disorder, eating disorder, OCD, PTSD or dementia
- Substance abuse in the last 6 months
- Pregnant or breast-feeding, unstable medical conditions or unstable doses of psychiatric or memory medicines
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- 55 - 85 years of age (on the day of randomization)
- are male or post-menopausal female
- have a diagnosis of mild cognitive impairment (MCI) based on Montreal Cognitive Assessment score < 26 or where available, results from clinical neuropsychological assessment, OR subjective memory concerns and first degree relative, living or deceased, with a probable or confirmed diagnosis of AD
- score 24 or higher on the Mini Mental State Examination (MMSE)
- are willing to provide informed consent
- are able to follow the treatment schedule
- are stable on medications for 2 months and are not expected to change medication during the entire study period (if they are taking medications)
- have a satisfactory safety screening questionnaire for TMS
Who cannot take part
- have a metal plate in their head(such as an ear implant, implanted brain stimulators, aneurysm clips). Dental devices and implants that are non-magnetic are safe
- have an implanted medication pump
- are on unstable doses of any psychotropic medication such as antidepressants, antipsychotic, mood stabilizers or memory enhancing medications
- have known increased pressure or a history of increased pressure in their brain, which may increase their risk for having seizures
- have a cardiac pacemaker
- have a history of any psychotic disorder, bipolar disorder, eating disorder, obsessive compulsive disorder, post-traumatic stress disorder, or dementia
- have a history of substance abuse in the last 6 months
- have a history of stroke or other brain lesions
- have a personal history of epilepsy
- have a family history of epilepsy
- have a history of abnormal MRI of the brain
- have unstable medical condition(s)
- have a central venous line
- are a pregnant or breast-feeding woman
- have untreated hypo- or hyper-thyroidism
- have any other known contraindications to TMS
- regularly use benzodiazepines or other hypnotics within 2 weeks of randomization
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 55 and 85 years old?
This trial is currently available in Canada.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol in combination with cognitive training can improve cognitive abilities in older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI). The study will look at whether it is safe and tolerable to use accelerated dTMS to enhance the benefits of cognitive training in older adults, and will also gather early information on the effects of accelerated dTMS on memory and other cognitive abilities.
The 2 groups in the trial
- 20-40 sessions of iTBS dTMS and 6-weeks of online cognitive remediationTreatment being tested
Treatment: Active Brainsway H7-Coil Deep TMS System
- 20-40 sessions of sham stimulation and 6-weeks of online cognitive remediationSham treatment, for comparison
Treatment: Sham Brainsway H1-Coil Deep TMS System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
- Plain-language title
- Magnetic brain stimulation with memory training for older adults with mild memory problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07212504, who can take part
- Record updated
- 28 October 2025